105 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned thereunto duly authorized. KODIAK SCIENCES INC. Date: March 31, 2026 By: /s/ Victor Perlroth Victor Perlroth, M.D. Chairman and Chief Executive Officer POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Victor Perlroth and John Borgeson, jointly and severally, as his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place, and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming that all said attorneys-in-fact and agents, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated: Signature Title Date /s/ Victor Perlroth Chairman and Chief Executive Officer (Principal Executive Officer) March 31, 2026 Victor Perlroth, M.D. /s/ John Borgeson Chief Financial Officer (Principal Financial and Accounting Officer) March 31, 2026 John Borgeson /s/ Felix J. Baker Director March 31, 2026 Felix J. Baker, Ph.D. /s/ Charles Bancroft Director March 31, 2026 Charles Bancroft /s/ Bassil I. Dahiyat Director March 31, 2026 Bassil I. Dahiyat, Ph.D. /s/ Richard S. Levy Director March 31, 2026 Richard S. Levy, M.D. /s/ Robert A. Profusek Director March 31, 2026 Robert A. Profusek, J.D. /s/ Taiyin Yang Director March 31, 2026 Taiyin Yang, Ph.D.